Opus Genetics, Inc. Balance Sheet
IRD|7 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Opus Genetics, Inc. had $50M in total assets and $7M in shareholders' equity as of FY2025. Total debt was $1M against $45M in cash, resulting in a $44M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2013 | FY2011 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45.1M | $30.3M | $50.5M | $42.6M | - | $13.5M | $12.3M |
| Accounts Receivable | $2.0M | $3.6M | $926.0K | $1.3M | - | - | - |
| Current Assets | $50.0M | $36.6M | $53.9M | $49.0M | $26.1M | $19.3M | $12.2M |
| PP&E (Net) | $199.0K | $252.0K | $0 | $6.0K | $10.0K | $65.2K | $94.5K |
| Total Assets | $50.2M | $36.9M | $53.9M | $49.0M | $26.1M | $19.6M | $13.7M |
| Current Liabilities | $7.8M | $11.3M | $4.0M | $2.8M | $3.9M | - | - |
| Total Debt | $1.1M | - | - | - | - | - | - |
| Shareholders' Equity | $6.7M | $49.9M | $46.2M | $22.2M | -$13.5M | $9.5M | $10.4M |